The three tissue types of interest are fairly easy to identify in most cases. Edema is bright on the FLAIR sequence, enhancing tumor is bright on T1 post-contrast and dark on pre-contrast, and necrosis is relatively dark on T1 pre- and post-contrast while also being surrounded by enhancing tumor. These rules hold true in most cases, so it’s really just a matter of having the algorithm find these simple patterns. The challenge in doing this manually is the amount of time it takes to create a really high quality 3D segmentation. It’s painful and very tough to do with just a mouse and 3 orthogonal planes to work with.
Currently, the accepted practice is to report these changes qualitatively without using segmentations (the way it’s been done for years). While the segmentations created by the models are probably good enough to use in practice today, the logistical challenges of integrating the model with the clinical workflow impede its actual use.
Sure, you could manually export your brain MR to run the model, but that’s a pain to do when you’re reading ~25 brain MR cases/day.
(I know nothing of this tbh, except I once had a demo of a radiologist back when the gamma knife was introduced, have a colleague who became a radiotherapist and a friend who works in ML for Philips medical.)
- from the "data" section of http://www.braintumorsegmentation.org/